| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/05/2011 | US20110107461 Cloning of novel gene sequences expressed and repressed during winter dormancy in the apical buds of tea |
| 05/05/2011 | US20110107444 Novel poly(adp-ribose) polymerase genes |
| 05/05/2011 | US20110107443 Novel protein transduction domains derived from secretory leukocyte protease inhibitor |
| 05/05/2011 | US20110105741 Nucleic acids encoding a g-protein coupled receptor involved in sensory transduction |
| 05/05/2011 | US20110105735 Methods of producing and purifying proteins |
| 05/05/2011 | US20110105723 Method of Detecting Malignancy of Nasopharyngeal Carcinoma and A Nasopharyngeal Carcinoma Malignancy Biomarker |
| 05/05/2011 | US20110105721 Peptides |
| 05/05/2011 | US20110105720 Protease stabilized, acylated insulin analogues |
| 05/05/2011 | US20110105718 Nel-related protein type 1 antibody |
| 05/05/2011 | US20110105415 Gene regulator |
| 05/05/2011 | US20110105414 Cyclic, cystein-free protein |
| 05/05/2011 | US20110105412 Conjugated molecules comprising a peptide derived from the cd4 receptor coupled to a polyanion for the treatment of aids |
| 05/05/2011 | US20110105411 Disease-Associated Proteins |
| 05/05/2011 | US20110105408 Therapeutic peptides |
| 05/05/2011 | US20110105407 Tissue Inhibitor of Metalloproteinases (Timp) Linked to Glycosylphosphatidylinositol (Gpi) - Anchors for Treatment of Cancer and Skin Lesions |
| 05/05/2011 | US20110105403 Peptides |
| 05/05/2011 | US20110105398 Recombinant fsh including alpha 2,3- and alpha 2,6-sailylatio |
| 05/05/2011 | US20110105396 Tgf-beta3 mutants |
| 05/05/2011 | US20110105394 Amylin Derivatives |
| 05/05/2011 | US20110105392 Pegylated Insulin Lispro Compounds |
| 05/05/2011 | US20110105391 Methods and Compositions for Delivering Peptides |
| 05/05/2011 | US20110105383 Methods and compositions for stimulation of mammalian innate immune resistance to pathogens |
| 05/05/2011 | US20110105382 Calmodulin-binding peptides that reduce cell proliferation in cancer and smooth muscle proliferation diseases |
| 05/05/2011 | US20110105379 Saccharide-containing protein conjugates and uses thereof |
| 05/05/2011 | US20110105362 Cyanine compounds and their application as quenching compounds |
| 05/05/2011 | US20110104806 Regulating the production of long chain hydrocarbons |
| 05/05/2011 | US20110104788 Modulation of Adenoviral Tropism |
| 05/05/2011 | US20110104781 Isolated phospholipid-protein particles |
| 05/05/2011 | US20110104759 Enzymes for starch processing |
| 05/05/2011 | US20110104753 Soluble Recombinant Influenza Antigens |
| 05/05/2011 | US20110104740 Fluorescent protein and chromoprotein |
| 05/05/2011 | US20110104715 Cytotoxic peptides and peptidomimetics based thereon, and methods for use thereof |
| 05/05/2011 | US20110104713 Products and processes for modulating peptide-peptide binding domain interactions |
| 05/05/2011 | US20110104711 GPR81-Ligand complexes and their preparation and use |
| 05/05/2011 | US20110104710 Construction of expression system for rna polymerase derived from influenza virus, crystallization of the rna polymerase, and screening method for anti-influenza agent |
| 05/05/2011 | US20110104705 Musclin receptor and use thereof |
| 05/05/2011 | US20110104681 Novel transgene assay using stable agrobacterium rhizogenes transformation |
| 05/05/2011 | US20110104668 Nucleic acid ligands against infectious prions |
| 05/05/2011 | US20110104666 Insulin resistance marker |
| 05/05/2011 | US20110104665 Mutant sodium channel nav 1.7 and methods related thereto |
| 05/05/2011 | US20110104657 Method of detecting malignancy of nasopharyngeal carcinoma and a nasopharyngeal carcinoma malignancy biomarker |
| 05/05/2011 | US20110104331 Glucose-induced inactivation/degradation-resistant transporter gene and use thereof |
| 05/05/2011 | US20110104263 Claudin-4 binding peptides, compositions and methods of use |
| 05/05/2011 | US20110104260 Vaccine against varicella zoster virus |
| 05/05/2011 | US20110104252 Anti-apoptotic gene scc-s2 and diagnostic and therapeutic uses thereof |
| 05/05/2011 | US20110104211 Compositions and methods for the therapy and diagnosis of breast cancer |
| 05/05/2011 | US20110104209 Dna sequence, and recombinant preparation of the grass pollen allergen lol p4 |
| 05/05/2011 | US20110104204 Systems and methods for identifying replikin scaffolds and uses of said replikin scaffolds |
| 05/05/2011 | US20110104201 Porcine Reproductive and Respiratory Syndrome Vaccine Based on Isolate JA-142 |
| 05/05/2011 | US20110104199 MVA Expressing Modified HIV Envelope, GAG, and POL Genes |
| 05/05/2011 | US20110104198 Consensus sequences of chikungunya viral proteins, nucleic acid molecules encoding the same, and compositions and methods for using the same |
| 05/05/2011 | US20110104194 Immunodominant mycobacterium tuberculosis peptides from cell wall proteins for early diagnosis and immunization |
| 05/05/2011 | US20110104193 Combination neisserial compositions |
| 05/05/2011 | US20110104192 Norovirus and sapovirus antigens |
| 05/05/2011 | US20110104191 Malva mosaic virus and virus-like particles and uses thereof |
| 05/05/2011 | US20110104190 Modified beta-lactoglobulins for immunotherapy of milk allergy |
| 05/05/2011 | US20110104178 Novel avian astrovirus |
| 05/05/2011 | US20110104171 EphA4 Polypeptide Having a Novel Activity and Use Thereof |
| 05/05/2011 | US20110104170 Novel composition and methods for the treatment of immune related diseases |
| 05/05/2011 | US20110104169 Regulator genes of angiogenesis, pharmaceutical preparations containing them and their applications |
| 05/05/2011 | US20110104168 Detoxified pneumococcal neuraminidase and uses thereof |
| 05/05/2011 | US20110104167 Compositions and Methods for Diagnosing and Treating Insulin Resistance |
| 05/05/2011 | US20110104152 Chimeric fibroblast growth factors with altered receptor specificity |
| 05/05/2011 | US20110104120 Directed Evolution and In Vivo Panning of Virus Vectors |
| 05/05/2011 | US20110104118 Compositions and methods for therapeutic use |
| 05/05/2011 | US20110104114 Polysaccharide-Protein Conjugates Reversibly Coupled Via Imine Bonds |
| 05/05/2011 | US20110104112 Targeted interferons demonstrate potent apoptotic and anti-tumor activities |
| 05/05/2011 | US20110104108 Methods of treating cancer and other conditions or disease states using lfmau and ldt |
| 05/05/2011 | US20110104103 Method of conjugating therapeutic compounds to cell targeting devices via metal complexes |
| 05/05/2011 | US20110104064 Cyclized non-native synthetic peptide and complex of peptides comprising said cyclized peptide, intended to induce and to characterize the prevention or treatment of conditions in mammals |
| 05/05/2011 | US20110104059 Membrane Associated Tumor Endothelium Markers |
| 05/05/2011 | US20110100371 Anti-viral properties of zosteric acid and related molecules |
| 05/05/2011 | US20110100263 Hot Spring Bacterial Strain BKH1 and Protein Isolated Therefrom, Concrete Compositions, and Uses Thereof |
| 05/05/2011 | DE10311106B4 Peptide gegen Kälteunverträglichkeit hervorrufende Autoantikörper, dafür kodierende Nukleinsäuren, ihre Verwendung und diese umfassende pharmazeutische Zusammensetzungen Peptides against cold intolerance inducing autoantibodies, nucleic acids encoding, their use and pharmaceutical compositions comprising |
| 05/05/2011 | CA2779816A1 Modified meningococcal fhbp polypeptides |
| 05/05/2011 | CA2779459A1 Peptide compositions and methods for inhibiting herpesvirus infection |
| 05/05/2011 | CA2779161A1 Yellow pea seed protein-derived peptides |
| 05/05/2011 | CA2778893A1 Dna vaccine against the yellow fever virus |
| 05/05/2011 | CA2778890A1 Glycosylated form of antigenic glp-1 analogue |
| 05/05/2011 | CA2778759A1 Tissue-regeneration promoter using recruitment of bone marrow mesenchymal stem cells and/or pluripotent stem cells in blood |
| 05/05/2011 | CA2778678A1 Improved neurturin molecules |
| 05/05/2011 | CA2778545A1 Drought tolerant plants and related constructs and methods involving genes encoding dtp21 polypeptides |
| 05/05/2011 | CA2778150A1 Modified neutral lipid encapsulating proteins and uses thereof |
| 05/05/2011 | CA2777705A1 Foot and mouth disease virus (fmdv) consensus proteins, coding sequences therefor and vaccines made therefrom |
| 05/05/2011 | CA2776241A1 Albumin variants |
| 05/05/2011 | CA2775369A1 Clonal expansion of b cells |
| 05/04/2011 | EP2317318A1 Fragments of fluorescent proteins for protein fragment complementation assays |
| 05/04/2011 | EP2317317A1 Prion protein ligands and methods of use |
| 05/04/2011 | EP2316966A1 CIZ1 replication protein |
| 05/04/2011 | EP2316959A2 Transgenic non-human animals for pharmacological and toxicological studies |
| 05/04/2011 | EP2316956A2 Plants having enhanced yield-related traits and a method for making the same |
| 05/04/2011 | EP2316953A2 Identification of novel E2F target genes and use thereof |
| 05/04/2011 | EP2316950A1 Single chain class I major histo-compatibility complexes, constructs encoding same and methods of generating same |
| 05/04/2011 | EP2316944A2 Binding agents: chimeric ligand/receptor proteins |
| 05/04/2011 | EP2316939A2 Novel peptide |
| 05/04/2011 | EP2316937A1 Dna encoding polypeptide involved in biosynthesis of herboxidiene |
| 05/04/2011 | EP2316925A1 Circovirus sequences associated with porcine wasting disease (PWD) |
| 05/04/2011 | EP2316924A2 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals |
| 05/04/2011 | EP2316923A2 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals |
| 05/04/2011 | EP2316920A1 Clonal expansion of B cells |